BICO Group AB engages in the provision of technologies, products, and services to create, understand, and master biology. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 695 full-time employees. The company went IPO on 2016-11-03. The firm focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The firm develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Follow-Up Questions
Quelle est la performance du prix de l'action CLLKF ?
Le prix actuel de CLLKF est de $2.55, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de BICO Group AB ?
BICO Group AB appartient à l'industrie Life Sciences Tools & Services et le secteur est Health Care
Quelle est la capitalisation boursière de BICO Group AB ?
La capitalisation boursière actuelle de BICO Group AB est de $176.4M
Est-ce que BICO Group AB est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 7 analystes ont établi des notations d'analystes pour BICO Group AB, y compris 2 achat fort, 6 achat, 1 maintien, 0 vente et 2 vente forte
